Get the Stockscreener App
13.85
0.93%
-0.13
After Hours:
13.74
-0.11
-0.79%
Benitec Biopharma Inc stock is traded at $13.85, with a volume of 21,980.
It is down -0.93% in the last 24 hours and up +11.78% over the past month.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
See More
Previous Close:
$13.98
Open:
$13.97
24h Volume:
21,980
Relative Volume:
0.20
Market Cap:
$363.57M
Revenue:
$59,000
Net Income/Loss:
$-21.81M
P/E Ratio:
-1.2646
EPS:
-10.9518
Net Cash Flow:
$-18.07M
1W Performance:
-0.43%
1M Performance:
+11.78%
6M Performance:
-4.42%
1Y Performance:
+69.73%
1-Day Range:
$13.71
$14.00
1-Week Range:
$13.30
$14.05
52-Week Range:
$8.06
$17.15
Benitec Biopharma Inc Stock (BNTC) Company Profile
Name
Benitec Biopharma Inc
Sector
Industry
Phone
(510) 780-0819
Address
3940 TRUST WAY, HAYWARD, CA
Compare BNTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
13.85 | 350.18M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Initiated | TD Cowen | Buy |
| Dec-16-24 | Initiated | H.C. Wainwright | Buy |
| Dec-13-24 | Initiated | Robert W. Baird | Outperform |
| Oct-16-24 | Initiated | Oppenheimer | Outperform |
| Sep-12-24 | Initiated | Guggenheim | Buy |
| Jul-22-24 | Initiated | Leerink Partners | Outperform |
| Jun-13-24 | Initiated | Piper Sandler | Overweight |
| Oct-05-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Apr-20-20 | Initiated | Ladenburg Thalmann | Buy |
| Feb-26-16 | Downgrade | Maxim Group | Buy → Hold |
| Dec-31-15 | Reiterated | Maxim Group | Buy |
| Sep-16-15 | Reiterated | Maxim Group | Buy |
View All
Benitec Biopharma Inc Stock (BNTC) Latest News
Combining price and volume data for Benitec Biopharma Inc.2025 Key Highlights & Risk Controlled Stock Alerts - Newser
Signal strength of Benitec Biopharma Inc. stock in tech scannersJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - Newser
Analyzing Benitec Biopharma Inc. with multi timeframe chartsJuly 2025 Trade Ideas & Fast Exit and Entry Strategy Plans - Newser
Can trapped investors hope for a rebound in Benitec Biopharma Inc.July 2025 Update & High Yield Stock Recommendations - Newser
Evaluating Benitec Biopharma Inc. with trendline analysis2025 Top Decliners & Smart Swing Trading Techniques - Newser
Benitec Biopharma Inc. stock chart pattern explained2025 Buyback Activity & Daily Profit Focused Screening - Newser
Analyzing net buyer seller activity in Benitec Biopharma Inc.Earnings Recap Report & Fast Gain Stock Trading Tips - Newser
Benitec Biopharma Inc. stock volume spike explainedTrade Risk Assessment & Long-Term Safe Investment Ideas - Newser
How to escape a deep drawdown in Benitec Biopharma Inc.July 2025 Catalysts & Free High Accuracy Swing Entry Alerts - Newser
Infinitum Asset Management LLC Raises Holdings in Benitec Biopharma Limited $BNTC - MarketBeat
Is Benitec Biopharma Inc. meeting your algorithmic filter criteriaWeekly Investment Summary & AI Forecasted Entry and Exit Points - Newser
Is Benitec Biopharma Inc. stock entering bullish territoryJuly 2025 Patterns & Free Community Consensus Stock Picks - Newser
Real time pattern detection on Benitec Biopharma Inc. stock2025 Volume Leaders & Reliable Entry Point Alerts - Newser
Benitec Biopharma Inc. stock daily chart insightsWeekly Trend Report & Daily Chart Pattern Signals - Newser
How to use Fibonacci retracement on Benitec Biopharma Inc.Market Activity Summary & Risk Controlled Swing Trade Alerts - Newser
Benitec Biopharma Limited (NASDAQ:BNTC) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Candlestick signals on Benitec Biopharma Inc. stock todayJuly 2025 Selloffs & Real-Time Volume Analysis - Newser
What earnings revisions data tells us about Benitec Biopharma Inc.July 2025 Sentiment & Community Trade Idea Sharing - Newser
Can Benitec Biopharma Inc. hit a new high this month2025 Breakouts & Breakdowns & Safe Entry Zone Tips - Newser
How to forecast Benitec Biopharma Inc. trends using time seriesPortfolio Risk Summary & High Win Rate Trade Tips - Newser
How to monitor Benitec Biopharma Inc. with trend dashboardsJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - Newser
Is this a good reentry point in Benitec Biopharma Inc.Market Weekly Review & Low Risk Growth Stock Ideas - Newser
What candlestick patterns are forming on Benitec Biopharma Inc.2025 Trading Recap & AI Enhanced Trading Signals - Newser
Short interest data insights for Benitec Biopharma Inc.Quarterly Profit Summary & Real-Time Stock Movement Alerts - Newser
Published on: 2025-09-09 06:59:34 - Newser
Multi asset correlation models including Benitec Biopharma Inc.July 2025 Reactions & Community Supported Trade Ideas - Newser
Benitec Biopharma Inc Stock (BNTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):